Equillium, Inc. (EQ) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
EQ currently has 63.2M outstanding shares. with significant dilution risk as 101M authorized shares could dilute existing holders by 159.6%. The company has significantly diluted shareholders by 82.21% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 63.2M shares outstanding |
63M | 100M |
| Apr 07, 2026 |
S-3 filing: This S-3 filing covers the offer and resale of 18,878,101 shares of common stock by a selling stockholder, including shares issuable upon the exercise of pre-funded warrants, with the company not receiving any proceeds from the sale. |
61M | 100M |
| Nov 13, 2025 |
S-3 filing: The company is filing an S-3 to register the offer and sale of up to $250,000,000 of common stock, preferred stock, and debt securities. |
61M | 85M |
| Nov 13, 2025 |
10-Q filing | 65.3M shares outstanding |
65M | 4.9M |
| Sep 09, 2025 |
S-3 filing: This is an S-3 filing for the offer and resale of up to 52,631,579 shares of common stock by selling stockholders, including shares issuable upon the exercise of pre-funded warrants, with the company not receiving any proceeds from the sale. |
60M | 11M |
| Aug 14, 2025 |
10-Q filing | 59.5M shares outstanding |
60M | 0 |
| May 14, 2025 |
10-Q filing | 35.6M shares outstanding |
36M | 0 |
| Mar 27, 2025 |
10-K filing | 35.4M shares outstanding |
35M | 0 |
| Nov 13, 2024 |
10-Q filing | 35.4M shares outstanding |
35M | 0 |
| Aug 08, 2024 |
10-Q filing | 35.3M shares outstanding |
35M | 0 |
| May 09, 2024 |
10-Q filing | 35.3M shares outstanding |
35M | 0 |
| Mar 25, 2024 |
10-K filing | 34.7M shares outstanding |
35M | 0 |
| Nov 08, 2023 |
10-Q filing | 34.9M shares outstanding |
35M | 0 |
| Aug 09, 2023 |
10-Q filing | 34.4M shares outstanding |
34M | 0 |
| May 11, 2023 |
10-Q filing | 34.4M shares outstanding |
34M | 0 |
| Mar 23, 2023 |
10-K filing | 33.7M shares outstanding |
34M | 0 |
| Jan 06, 2023 |
S-3 filing: The filing is an S-3 registration statement for a shelf offering of up to $250,000,000 of common stock, preferred stock, debt securities, and warrants. |
34M | 0 |
| Nov 14, 2022 |
10-Q filing | 34.4M shares outstanding |
34M | 0 |
| Aug 15, 2022 |
10-Q filing | 34.3M shares outstanding |
34M | 0 |
| May 12, 2022 |
10-Q filing | 34.3M shares outstanding |
34M | 0 |
| Mar 23, 2022 |
10-K filing | 34.3M shares outstanding |
34M | 0 |
| Nov 10, 2021 |
10-Q filing | 29.4M shares outstanding |
29M | 0 |
| Aug 10, 2021 |
10-Q filing | 29.4M shares outstanding |
29M | 0 |
| May 13, 2021 |
10-Q filing | 29.0M shares outstanding |
29M | 0 |
| Mar 24, 2021 |
10-K filing | 29.0M shares outstanding |
29M | 0 |
| Feb 04, 2021 |
8-K filing: Equillium, Inc. entered into a securities purchase agreement with two leading life sciences investors managed by Decheng Capital, relating to the issuance and sale of 4,285,710 units, with each Unit consisting of one share of the Company's common stock and a warrant to purchase 0.3 of a share of Common Stock for gross proceeds of approximately $30 million. ($60.0M proceeds) |
25M | 0 |
| Nov 10, 2020 |
10-Q filing | 24.7M shares outstanding |
25M | 0 |
| Aug 14, 2020 |
8-K filing: Equillium, Inc. entered into an underwriting agreement for a public offering of 5,000,000 shares of common stock at $7.00 per share, with an option for the underwriters to purchase up to 750,000 additional shares. ($35.0M proceeds) |
19M | 0 |
| Aug 12, 2020 |
10-Q filing | 19.3M shares outstanding |
19M | 0 |
| May 13, 2020 |
10-Q filing | 17.7M shares outstanding |
18M | 0 |
| Mar 30, 2020 |
S-1 filing: This S-1 filing describes a potential offering of common stock by a selling stockholder. The company will pay the expenses of registering these shares, but all selling and other expenses incurred by the selling stockholder will be paid by the selling stockholder. |
18M | 0 |
| Mar 26, 2020 |
10-K filing | 17.6M shares outstanding |
18M | 0 |